Delivery Order SPE2DB25D3306-SPE2DB25FUCQK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,826.71 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in respiratory disease treatment. This firm fixed-price delivery order, issued on July 18, 2025, represents a competitive award with no set-aside designation and is scheduled for completion by July 21, 2025. The product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $9,325.77 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Trelegy Ellipta 200-62.5-25, a combination inhalation powder medication used in respiratory disease treatment. This non-set-aside, firm fixed-price delivery order is scheduled for completion by September 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $7,008.86 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in respiratory disease management. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 8, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania, supporting the federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,143.65 for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in respiratory disease management. This competitively awarded, firm fixed-price delivery order was issued on September 11, 2025, with an ultimate completion date of September 12, 2025, and represents a direct purchase under an existing contract vehicle. The award carries no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $34,691.15 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used in respiratory disease management. The order, issued on September 12, 2025, with completion targeted for September 15, 2025, represents a firm fixed price transaction with no set-aside designation, indicating competitive award through open procurement. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $9,149.22 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation powder medication used in respiratory disease treatment. This firm fixed-price delivery order, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-competitive, non-set-aside procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,001.90 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in respiratory disease management. This firm fixed-price delivery order, issued on July 14, 2025, with an ultimate completion date of July 15, 2025, represents a non-competitive, non-set-aside award. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,604.40 for TRELEGY ELLIPTA 100-62.5-25 (60 count), a combination inhalation powder used in respiratory disease treatment. Issued on September 2, 2025, with an ultimate completion date of September 3, 2025, this firm fixed-price delivery order represents a routine pharmaceutical supply transaction under a non-competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $10,859.04 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder used to treat chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order was issued on September 11, 2025, with an ultimate completion date of September 12, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $21,739.01 to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of TRELEGY ELLIPTA 200-62.5-25, a combination respiratory medication, with an ultimate completion date of August 25, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCQKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,667.30 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used in respiratory therapy, on August 14, 2025. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 15, 2025, and represents fulfillment under AmerisourceBergen's existing pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion comprehensive global pharmaceutical support vehicle valued through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies an extensive portfolio of medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. The company has demonstrated capability to meet federal procurement requirements through competitive award processes, serving customers including the Defense Health Agency and U.S. Coast Guard across multiple therapeutic domains through this flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 8/14/25 |